1.

SARS-CoV-2 seroprevalence among employees of a university hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study)

1.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium between 2013 and 2019

1.

Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019

1.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019

1.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019.

2.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019.

3.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019.

1.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

2.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

3.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

4.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

5.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

6.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

7.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

1.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.

2.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.

3.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.

1.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

2.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

3.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

1.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

2.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

3.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

4.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

5.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

6.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

7.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

8.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

9.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migran...

1.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

2.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

3.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

4.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

5.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

6.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

7.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

8.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

9.

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium